Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Summary
To compare the efficacy and safety of the combination of alogliptin and actoplus met with that of actoplus met alone in improving the glucose and lipid metabolism and pancreatic function in T2DM patients complicated with MAFLD.
Official title: The Effect of Alogliptin Combined With Pioglitazone and Metformin Hydrochloride Tablets on Glucose and Lipid Metabolism and Islet Function in Patients With Type 2 Diabetes Mellitus Complicated With Metabolic Dysfunction-associated Fatty Liver Disease
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2026-05-01
Completion Date
2027-08-31
Last Updated
2026-03-24
Healthy Volunteers
No
Interventions
alogliptin and actoplus met
combination of alogliptin and actoplus met
actoplus met
actoplus met